+986.4%
MRNA vs LDOS
-30.4%
+1,016.8%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | LDOS | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.8% | +2.3% | +3.5% | +4.6% |
| 7D | +21.8% | -5.8% | +27.6% | +25.2% |
| 30D | +19.6% | +11.6% | +8.0% | +10.9% |
| 3M | +354.6% | -1.0% | +355.6% | +366.9% |
| 6M | +394.9% | +5.1% | +389.9% | +400.2% |
| YTD | +812.2% | -24.0% | +836.2% | +925.2% |
| All | +986.4% | -30.4% | +1,016.8% | +1,202.1% |
Cumulative growth
Daily Returns
Daily percentage return beside LDOS.
Daily Out/Under-Performance
Portfolio return minus LDOS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × LDOS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded LDOS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling